s6y

Laboratory Analytical Instruments

25 listed companies the SEC classes under this industry (code 3826), in order of revenue.

24 of them have annual figures on record. The 24 reporting in US dollars had revenue of $35.3B between them in their latest fiscal years.

Company Fiscal year to
Agilent Technologies, Inc. Oct 2025 $6.95B$1.30B$12.7B
Avantor, Inc. Dec 2025 $6.55B−$530.2M$11.8B
Illumina, Inc. Dec 2025 $4.34B$850.0M$6.64B
Mettler Toledo International Inc Dec 2025 $4.03B$869.2M$3.71B
Bruker Corp Dec 2025 $3.44B−$8.60M$6.24B
Waters Corp Dec 2025 $3.17B$642.6M$5.08B
Revvity, Inc. Dec 2025 $2.86B$241.2M$12.2B
Bio-RAD Laboratories, Inc. Dec 2025 $2.58B$759.9M$10.6B
10x Genomics, Inc. Dec 2025 $642.8M−$43.5M$1.04B
Cytek Biosciences, Inc. Dec 2025 $201.5M−$66.5M$461.5M
Pacific Biosciences of California, Inc. Dec 2025 $160.0M−$546.4M$784.1M
Quanterix Corp Dec 2025 $138.9M−$107.2M$418.8M
Harvard Bioscience Inc Dec 2025 $86.5M−$56.7M$80.1M
908 Devices Inc. Dec 2025 $56.2M$19.5M$190.1M
Rapid Micro Biosystems, Inc. Dec 2025 $33.6M−$47.1M$74.9M
EyePoint, Inc. Dec 2025 $31.4M−$232.0M$364.0M
Bionano Genomics, Inc. Dec 2025 $28.5M−$26.4M$73.6M
Precipio, Inc. Dec 2025 $24.2M−$363.0K$21.3M
Seer, Inc. Dec 2025 $16.6M−$73.6M$296.1M
Lifeloc Technologies, Inc Dec 2025 $9.03M−$2.47M$6.69M
Scientific Industries Inc Dec 2025 $5.05M−$1.22M$12.6M
Astrotech Corp Jun 2026 $913.0K−$14.4M$20.5M
Nautilus Biotechnology, Inc. Dec 2025 –−$59.0M$191.1M
Bioforce Nanosciences Holdings, Inc. Dec 2025 –−$1.29M$786
Alamar Biosciences, Inc.

Each company's latest fiscal year, as its annual report to the SEC gave the figures; the year links to that report. Amounts in other currencies are not converted, and sort after those in dollars.